A final but unsatisfied award is usually not recognised as an asset for accounting purposes, yet continues to consume cost to manage. That mismatch creates room to transact.
Why holders sell
The seller's motive is typically not doubt about merits but three specific pressures: a fund approaching the end of its life and needing an exit; financial statements carrying a long-standing receivable; and internal resource unable to keep feeding a long enforcement process. None of those relates to legal merits — which is exactly why acquisition can clear at a fair price.
The variables that drive price
Our model decomposes price into four terms: the present value of identifiable assets, the probability those assets are moved, the expected distribution of enforcement duration, and the cost of piercing. Estimation error is largest on the second and third, and that is where pricing capability separates.
Why China-related claims trade at a structural discount
Offshore buyers generally lack the ability to assess mainland enforcement conditions, the routes to obtain asset leads, and local judicial practice. They therefore apply a substantial uncertainty discount to China-related claims. An institution with onshore underwriting capability can capture the spread between that discount and the true risk. That is the economic basis of ArbiHonor's business.
Keep reading
The limits of claim assignment under PRC law: the legal basis for acquisition
Outright assignment is not novel under PRC law, but its validity turns on conditions that are easily overlooked.
How funding an estate lifts the unsecured distribution
Administrators abandon recovery claims primarily because the estate cannot fund them, not because the claims lack merit.
The ArbiHonor Quarterly, Q3 2026: How acquisition structures reprice enforceability
When the funder becomes the claim holder, underwriting shifts from merits to enforceability. This issue unpacks what that does to the pricing model.
Does this change touch your claim?
Send us the facts. The underwriting team will read them against this development and tell you where it bites — at no cost.